Thulium LASER is fast emerging as a safe and effective modality for benign prostatic hyperplasia (BPH). Still, compared to holmium laser transurethral enucleation of the prostate (HoLEP) the number of institutes all over the world using Thulium LASER are limited.
This is our effort to bring the statistical facts about the safety and effectivity of Thulium LASER.
To study the efficacy of thulium laser enucleation of the prostate (ThuLEP).
All patients in the stipulated period were documented for all parameters and were evaluated. The results were tabulated.
(1) Two hundred and thirty-six patients with symptomatic BPH were treated with ThuLEP between March 2010 and September 2014 at our institute by a single surgeon. (2) The inclusion criteria were maximum urinary flow rate (Qmax) <15 ml/s, International Prostate Symptoms Score (IPSS) >15 or acute retention of urine with the failure of catheter trial or Acute retention of urine with prior history of severe bladder outlet obstruction. (3) Patients evaluated by: Digital rectal examination, uroflowmetry, IPSS, prostate-specific antigen (PSA), blood and urine routine tests, abdominal usage with trains rectal ultrasonography (TRUS), TRUS guided biopsies.
(1) ThuLEP was a highly effective procedure as compared to all other procedures like HOLEP, TURP in terms of catheterization time, hospital stay, and drop in hemoglobin (Hb). (2) Catheterization time: 25. 22 h (224 patients within 24 h and 12 patients within 48 h). (3) Hospital stay: 24-36 h 218 patients (92. 3%), 36-48 h 18 patients (7. 6%). (4) Drop in Hb: 0. 8 ± 0. 42 g/dl. (5) Average operative time: 56. 91 min.
Thulium LASER is a safe and highly effective LASER in terms of blood loss, speed of tissue resection, drop in serum PSA, and versatility of prostatic resection.
Urology annals. 0000 [Epub]
P Vartak Ketan, H Salvi Prashant
Pramodini Urology Foundation, Pune, Maharashtra, India. , Pramodini Urology Foundation, Pune, Maharashtra, India.